ceFAZolin sodium in Sterile Water for injection, Injectable Solution, 1g/10mL (0.1 g per mL), Syringe, Rx only, Wells Pharma, NDC 73702-131-10
Published December 13, 2023 · Recall initiated: November 22, 2023
Summary
FDA records drug Class II recall D-0141-2024, published December 13, 2023 and initiated November 22, 2023. Recalling firm: Wells Pharma of Houston LLC; Status: Completed; Reported quantity: 825 syringes; Lot: Lot # 11092313110#01, Exp 01/12/24. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Completed — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Lack of assurance of sterility.
What to do
Voluntary: Firm initiated · Telephone
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Wells Pharma of Houston LLC
- Distributor
- Philadelphia, Pennsylvania.
- Lot
- Lot # 11092313110#01, Exp 01/12/24
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAKetamine Hydrochloride Injectable Solution, 50mg/ml, (50 mg per mL) Volume: 1 mL, 5265 Kitty Drive, Houston,May 6, 2026
- FDAfentaNYL Citrate Injectable Solution in 0.9% Sodium Chloride, 1000 mcg/50mL (20 mcg per mL), well pharma ofMay 6, 2026
- FDAfentaNYL Citrate injectable Solution in 0.9% Sodium Chloride, Narcotic, (2500 mcg/ 250 mL) (10 mcg per mL),May 6, 2026
- FDAfentaNYL Citrate Injectable Solution, NARCOTIC, Cii, 1000 mcg/100 mL (10 mcg per mL), 100 mL bag, Wells PharmaMay 6, 2026
- FDALET Gel (Lidocaine HCL/Epinephrine Bitartrate/Tetracaine HCL 4%/0.18%/0.5% Topical Gel), Single-use TopicalDecember 13, 2023
- FDAKinderMed KIDS' PAIN & FEVER Acetaminophen, 160 mg per 5 mL bottles, Oral Suspension, Organic Cherry Flavor, 4December 13, 2023
Questions about this recall
Was ceFAZolin sodium in Sterile Water for injection, Injectable Solution, 1g/10mL (0.1 g per mL), Syringe, Rx only, Wells Pharma, NDC 73702-131-10 recalled?
Yes. FDA published recall D-0141-2024 on December 13, 2023. Reported hazard: Lack of assurance of sterility.
What should I do if I have this product?
Voluntary: Firm initiated · Telephone